Cerence (CRNC) EVP granted 87,796 restricted stock units at $12.35

Rhea-AI Filing Summary

Cerence Inc. executive Nils Schanz, EVP Product & Technology, reported receiving a grant of 87,796 shares of common stock on January 9, 2026. The filing describes this as a grant of restricted stock units under a Restricted Stock Unit Agreement at a reported price of $12.35 per share. According to the footnote, the shares vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Schanz beneficially owns 342,682 shares of Cerence common stock, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schanz Nils

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Product & Technology

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		87,796(1)	A	$12.35	342,682	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Stock Units subject to the Restricted Stock Unit Agreement. Shares vest one-third on each of October 1, 2026, 2027, and 2028.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cerence (CRNC) report in this Form 4?

The Form 4 reports that EVP Product & Technology Nils Schanz received a grant of 87,796 shares of Cerence common stock as restricted stock units on January 9, 2026.

At what price were the Cerence (CRNC) shares granted to Nils Schanz?

The restricted stock unit grant to Nils Schanz is reported at a price of $12.35 per share for 87,796 shares of Cerence common stock.

How do the restricted stock units granted to Cerence executive Nils Schanz vest?

The restricted stock units granted to Nils Schanz vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028.

How many Cerence (CRNC) shares does Nils Schanz own after this Form 4 transaction?

Following the reported grant, Nils Schanz beneficially owns 342,682 shares of Cerence common stock, held in direct ownership.

What is the role of the reporting person in this Cerence (CRNC) Form 4?

The reporting person, Nils Schanz, is an officer of Cerence Inc., serving as EVP Product & Technology, and filed the Form 4 as a single reporting person.

Does this Cerence (CRNC) Form 4 report any derivative securities?

No derivative securities are listed with transactions in the provided portion of the Form 4; the reported activity involves common stock via restricted stock units.